Clinical Trial Update: Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA) [Phase 2]

View source ↗

Summary

A completed Phase 2 trial (NOVA) evaluating botulinum toxin type A (AGN-151607) for prevention of postoperative atrial fibrillation in adults undergoing open-ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Atrial Fibrillation

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: AbbVie | Conditions: Post-Operative Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2024-05-14